TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) Investor Securities Class Action Lawsuit 12/18/2015

  • If you purchased shares of KaloBios Pharmaceuticals Inc (NASDAQ: KBIO), you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

August 2, 2018 - The court approved the settlement. April 2, 2018 - The court granted an amended order preliminarily approving the settlement. March 29, 2018 - The court preliminarily approved the settlement. March 29, 2018 - The court ordered the authorization of the distribution of the net settlement fund. March 21, 2018 - Parties (lead plaintiffs and a certain defendant) filed ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: